taxonomy (6)
protein (16)
source (11)
structure (14)
composition (1)
disease (4)
reference (16)
site (28)
peptide (39)
- Homo sapiens (Human)
- Sus scrofa (Pig)
- Bufo bufo (European toad)
- Rana utricularia
- Apis mellifera (Honeybee)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- CD59 glycoprotein / Homo sapiens P13987
- Immunoglobulin heavy constant gamma 1 / Homo sapiens P01857
- Immunoglobulin heavy constant gamma 4 / Homo sapiens P01861
- Immunoglobulin heavy constant mu / Homo sapiens P01871
- Latent transforming growth factor beta binding protein 1 / Homo sapiens Q14766
- Unspecified mucin / Homo sapiens
- Major seminal plasma glycoprotein psp-i / Sus scrofa P35495
- Major seminal plasma glycoprotein psp-ii / Sus scrofa P35496
- Mucin / Sus scrofa
- Uncharacterized protein from Epithelium of Stomach / Sus scrofa
- Mucin / Bufo bufo
- Mucin / Rana utricularia
- Hyaluronoglucosaminidase / Apis mellifera Q08169
- Phospholipase a2 / Apis mellifera P00630
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Blood Serum (UBERON_0001977)
- Epithelium of Stomach (UBERON_0001276)
- Mucosa of Stomach (UBERON_0001199)
- Pulmonary Mucosa
- Seminal Fluid (UBERON_0006530)
- Urine (UBERON_0001088)
- Venom (UBERON_0007113)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- Egg Cell Jelly Coat
Source
- N-Linked / Complex / Fuc(a1-3)[GalNAc(b1-4)]GlcNAc(b1-2)Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)]GlcNAc
- N-Linked / Complex / Fuc(a1-3)[GalNAc(b1-4)]GlcNAc(b1-2)Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-?)Man(a1-3)[GlcNAc(b1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)][Fuc(a1-6)]GlcNAc
- O-Linked / Core 2 / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-?)GlcNAc(b1-3)Gal(b1-3)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)]Gal(b1-3)[GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)Gal(b1-3)[Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)]Gal(b1-3)[GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)[GlcNAc(b1-6)]Gal(b1-3)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)]GlcNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-?)GlcNAc(b1-3)[Fuc(a1-2)Gal(b1-?)GlcNAc(b1-6)]Gal(b1-3)[GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Gal(a1-3)GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-3)[Fuc(a1-2)][GlcNAc(b1-6)]Gal(b1-3)[GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Gal(b1-3)GlcNAc(a1-3)[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-6)[Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-3)]GalNAc
- O-Linked / Core 4 / Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-3)]GalNAc
- O-Linked / Core 4 / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)[Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)]GalNAc
- O-Linked / Core 4 / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)]GalNAc
Reported structure
- Hex:3 HexNAc:4 dHex:2 (avg mass : 1609.5085 )
Composition
- Bronchiectasis, due to Kartagener's Syndrome
- COVID-19 (DOID:0080600)
- Cystic Fibrosis (DOID:1485)
- Prostate cancer (DOID:10283)
Disease
- Site-specific analysis of the SARS-CoV-2 glycan shield (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Hybrid and complex glycans are linked to the conserved N-glycosylation site of the third eight-cysteine domain of LTBP-1 in insect cells. (2000 - Rudd P, Downing A, Cadene M, Harvey D, Wormald M, Weir I, Dwek R, Rifkin D, Gleizes P) / Status : Reviewed
- Structural characterization of the oligosaccharide chains of native and crystallized boar seminal plasma spermadhesin PSP-I and PSP-II glycoforms. (1999 - Nimtz M, Grabenhorst E, Conradt H, Sanz L, Calvete J) / Status : Reviewed
- Structural analysis of a new series of oligosaccharide-alditols released by reductive beta-elimination from oviducal mucins of Rana utricularia. (1998 - Morelle W, Strecker G) / Status : Reviewed
- Structural analysis of hexa to dodecaoligosaccharide-alditols released by reductive beta-elimination from oviducal mucins of Bufo bufo. (1997 - Morelle W, Strecker G) / Status : Reviewed
- The asparagine-linked carbohydrate of honeybee venom hyaluronidase. (1995 - Kubelka V, Altmann F, Mrz L) / Status : Reviewed
- Primary structures of the N-linked carbohydrate chains from honeybee venom phospholipase A2. (1993 - Kubelka V, Altmann F, Staudacher E, Tretter V, Mrz L, Hrd K, Kamerling J, Vliegenthart J) / Status : Reviewed
- Quantitation and structures of oligosaccharide chains in human trachea mucin glycoproteins. (1992 - Sangadala S, Bhat U, Mendicino J) / Status : Reviewed
- Isolation and structural characterization of novel neutral oligosaccharide-alditols from respiratory-mucus glycoproteins of a patient suffering from bronchiectasis. 1. Structure of 11 oligosaccharides having the GlcNAc beta(1---3)Gal beta(1---4)GlcNAc beta(1---6)GalNAc-ol structural element in commo (1991 - Klein A, Carnoy C, Lamblin G, Roussel P, van Kuik J, de Waard P, Vliegenthart J) / Status : Reviewed
- Isolation and structural characterization of novel neutral oligosaccharide-alditols from respitatory-mucus glycoproteins of a patient suffering from bronchiectasis. 2. Structure of twelve hepta-to-nonasaccharide, six of which possess the GlcNAc beta(1----3)[Gal beta(1----4)GlcNAc beta(1----6)]Gal be (1991 - van Kuik J, de Waard P, Vliegenthart J, Klein A, Carnoy C, Lamblin G, Roussel P) / Status : Reviewed
- Structural characterization of neutral oligosaccharides of human H+Leb+ gastric mucin. (1984 - Slomiany B, Zdebska E, Slomiany A) / Status : Reviewed
- Structures of the oligosaccharide chains in swine trachea mucin glycoproteins. (1984 - Chandrasekaran EV, Rana SS, Davila M, Mendicino J) / Status : Reviewed
- Characterization of the primary structure and the microheterogeneity of the carbohydrate chains of porcine blood-group H substance by 500-MHz 1H-NMR spectroscopy. (1982 - van Halbeek H, Dorland L, Vliegenthart J, Kochetkov N, Arbatsky N, Derevitskaya V) / Status : Reviewed
Reference
- CD59 glycoprotein / Homo sapiens
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
- Immunoglobulin heavy constant gamma 4 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
Unspecified mucin / Homo sapiens
- Undefined site
- Major seminal plasma glycoprotein psp-i / Sus scrofa
- Major seminal plasma glycoprotein psp-ii / Sus scrofa
-
Mucin / Sus scrofa
- Undefined site
-
Uncharacterized protein from Epithelium of Stomach / Sus scrofa
- Undefined site
-
Mucin / Bufo bufo
- Undefined site
-
Mucin / Rana utricularia
- Undefined site
-
Hyaluronoglucosaminidase / Apis mellifera
- Undefined site
- Phospholipase a2 / Apis mellifera
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- FVFLVLLPLVSSQCVNLT (18aa)
- FVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFT (32aa)
- QCVNLTTR (8aa)
- VFLVLLPLVSSQCVNLTTR (19aa)
- VLLPLVSSQCVNLTTR (16aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGT (32aa)
- HAIHVSGTNGTK (12aa)
- DLCNFNEQLENGGTSLSEK (19aa)
- SLLIVNNATNVVIK (14aa)
- TTLDSKTQSLLIVNNATNVVIK (22aa)
- TLDSKTQSLLIVNNATNVVIK (21aa)
- VYSSANNCT (9aa)
- SANNCTFEYVSQPFLMDLEGK (21aa)
- SKHTPINLVRDLPQGFSALEPLVDLPIGINITR (33aa)
- PIGINITRFQTLLALHR (17aa)
- YSKHTPINLVRDLPQGFSALEPLVDLPIGINITR (34aa)
- LVRDLPQGFSALEPLVDLPIGINITRFQTLLALHR (35aa)
- DLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYY (52aa)
- LPIGINITRFQTLLALHR (18aa)
- PLVDLPIGINITRFQTLLALHR (22aa)
- DLPQGFSALEPLVDLPIGINIT (22aa)
- HTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLA (37aa)
- ALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPR (52aa)
- NLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHR (36aa)
- GINITR (6aa)
- YNENGTITDAVDCALDPLSET (21aa)
- NITNLCPFGEVFNATR (16aa)
- VQPTESIVRFPNITNLCP (18aa)
- RFPNIT (6aa)
- VLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (73aa)
- SLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTK (36aa)
- IAIPTNFTISVTTEILPVSMTK (22aa)
- NFSQILPDPSKPSKR (15aa)
- TPPIKDFGGFNFSQILPD (18aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVM (38aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAI (36aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIV (37aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSC (52aa)
- CDNVLAPNVTKQECCCTSGVGWGDNCEIFPC (31aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex (avg mass : 1609.5085)
- Venom (UBERON_0007113)
- The asparagine-linked carbohydrate of honeybee venom hyaluronidase. (1995 - Kubelka V, Altmann F, Mrz L) / Status : Reviewed
- Primary structures of the N-linked carbohydrate chains from honeybee venom phospholipase A2. (1993 - Kubelka V, Altmann F, Staudacher E, Tretter V, Mrz L, Hrd K, Kamerling J, Vliegenthart J) / Status : Reviewed
-
Hyaluronoglucosaminidase / Apis mellifera
- Undefined site
- Phospholipase a2 / Apis mellifera
-
- N-Linked / Complex (avg mass : 1609.5085)
- Structural characterization of the oligosaccharide chains of native and crystallized boar seminal plasma spermadhesin PSP-I and PSP-II glycoforms. (1999 - Nimtz M, Grabenhorst E, Conradt H, Sanz L, Calvete J) / Status : Reviewed
- The asparagine-linked carbohydrate of honeybee venom hyaluronidase. (1995 - Kubelka V, Altmann F, Mrz L) / Status : Reviewed
- Primary structures of the N-linked carbohydrate chains from honeybee venom phospholipase A2. (1993 - Kubelka V, Altmann F, Staudacher E, Tretter V, Mrz L, Hrd K, Kamerling J, Vliegenthart J) / Status : Reviewed
- Major seminal plasma glycoprotein psp-i / Sus scrofa
- Major seminal plasma glycoprotein psp-ii / Sus scrofa
-
Hyaluronoglucosaminidase / Apis mellifera
- Undefined site
- Phospholipase a2 / Apis mellifera
-
- N-Linked / Complex (avg mass : 1609.5085)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- O-Linked / Core 2 (avg mass : 1609.5085)
- Pulmonary Mucosa
- Cystic Fibrosis (DOID:1485)
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 2 (avg mass : 1609.5085)
- Pulmonary Mucosa
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 2 (avg mass : 1609.5085)
- Pulmonary Mucosa
- Cystic Fibrosis (DOID:1485)
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 2 (avg mass : 1609.5085)
-
Uncharacterized protein from Epithelium of Stomach / Sus scrofa
- Undefined site
-
- O-Linked / Core 2 (avg mass : 1609.5085)
- Pulmonary Mucosa
-
Mucin / Sus scrofa
- Undefined site
-
- O-Linked / Core 2 (avg mass : 1609.5085)
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 2 (avg mass : 1609.5085)
- Egg Cell Jelly Coat
-
Mucin / Bufo bufo
- Undefined site
-
- O-Linked / Core 2 (avg mass : 1609.5085)
- Egg Cell Jelly Coat
-
Mucin / Rana utricularia
- Undefined site
-
- O-Linked / Core 4 (avg mass : 1609.5085)
- Pulmonary Mucosa
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 4 (avg mass : 1609.5085)
- Pulmonary Mucosa
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 4 (avg mass : 1609.5085)
- Pulmonary Mucosa
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- Hex:3 HexNAc:4 dHex:2 / N-Linked (avg mass : 1609.5085)
- N-Linked / Complex / Fuc(a1-3)[GalNAc(b1-4)]GlcNAc(b1-2)Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-?)Man(a1-3)[GlcNAc(b1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)][Fuc(a1-6)]GlcNAc
- COVID-19 (DOID:0080600)
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Site-specific analysis of the SARS-CoV-2 glycan shield (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
- Immunoglobulin heavy constant gamma 4 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FVFLVLLPLVSSQCVNLT (18aa)
- FVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFT (32aa)
- QCVNLTTR (8aa)
- VFLVLLPLVSSQCVNLTTR (19aa)
- VLLPLVSSQCVNLTTR (16aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGT (32aa)
- HAIHVSGTNGTK (12aa)
- SLLIVNNATNVVIK (14aa)
- TTLDSKTQSLLIVNNATNVVIK (22aa)
- TLDSKTQSLLIVNNATNVVIK (21aa)
- VYSSANNCT (9aa)
- SANNCTFEYVSQPFLMDLEGK (21aa)
- SKHTPINLVRDLPQGFSALEPLVDLPIGINITR (33aa)
- PIGINITRFQTLLALHR (17aa)
- YSKHTPINLVRDLPQGFSALEPLVDLPIGINITR (34aa)
- LVRDLPQGFSALEPLVDLPIGINITRFQTLLALHR (35aa)
- DLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYY (52aa)
- LPIGINITRFQTLLALHR (18aa)
- PLVDLPIGINITRFQTLLALHR (22aa)
- DLPQGFSALEPLVDLPIGINIT (22aa)
- HTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLA (37aa)
- ALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPR (52aa)
- NLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHR (36aa)
- GINITR (6aa)
- YNENGTITDAVDCALDPLSET (21aa)
- NITNLCPFGEVFNATR (16aa)
- VQPTESIVRFPNITNLCP (18aa)
- RFPNIT (6aa)
- VLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (73aa)
- SLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTK (36aa)
- IAIPTNFTISVTTEILPVSMTK (22aa)
- NFSQILPDPSKPSKR (15aa)
- TPPIKDFGGFNFSQILPD (18aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVM (38aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAI (36aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIV (37aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSC (52aa)
-
- Hex:3 HexNAc:4 dHex:2 / O-Linked (avg mass : 1609.5085)
- Urine (UBERON_0001088)
- O-Linked / Core 2 / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-?)GlcNAc(b1-3)Gal(b1-3)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)]Gal(b1-3)[GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)Gal(b1-3)[Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)]Gal(b1-3)[GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)[GlcNAc(b1-6)]Gal(b1-3)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)]GlcNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-?)GlcNAc(b1-3)[Fuc(a1-2)Gal(b1-?)GlcNAc(b1-6)]Gal(b1-3)[GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Gal(b1-3)GlcNAc(a1-3)[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-6)[Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-3)]GalNAc
- O-Linked / Core 4 / Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-3)]GalNAc
- O-Linked / Core 4 / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)[Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)]GalNAc
- O-Linked / Core 4 / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)]GalNAc
- Prostate cancer (DOID:10283)
- CD59 glycoprotein / Homo sapiens
- DLCNFNEQLENGGTSLSEK (19aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Reported glycosite
Source
Reported glycosite
Source
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Disease
Reported glycosite
Source
Disease
Reported glycosite
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Disease
Reference
Reported glycosite
Source
Disease
Reference
Reported glycosite
